Climb Bio | 4:持股变动声明-高管 Pimblett Emily
Climb Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(3.23%),Deep Track Biotechnology Master Fund, Ltd.(3.23%)等
Climb Bio | 4:持股变动声明-董事 WILLIAMS DOUGLAS E
Climb Bio | 3:首次持股声明-董事 WILLIAMS DOUGLAS E
Eliem Therapeutics | 4:持股变动声明-高管 Pimblett Emily
Eliem Therapeutics | 4:持股变动声明-高管 Kaplan Brett
Eliem Therapeutics | 3:首次持股声明-高管 Kaplan Brett
Eliem Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)
Eliem Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | 4:持股变动声明-高管 Morisset Valerie
Eliem Therapeutics | D:发行公告
Eliem Therapeutics | D:发行公告
Eliem Therapeutics | SC 13G:超过5%持股股东披露文件-Deep Track Capital, LP(5.85%),Deep Track Biotechnology Master Fund, Ltd.(5.85%)等
Eliem Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.